BioLine RX Ltd (BLRX.OQ)

BLRX.OQ on NASDAQ Stock Exchange Capital Market

1.56USD
19 Sep 2014
Price Change (% chg)

$-0.06 (-3.70%)
Prev Close
$1.62
Open
$1.55
Day's High
$1.61
Day's Low
$1.55
Volume
41,811
Avg. Vol
19,345
52-wk High
$3.33
52-wk Low
$1.50

BLRX.OQ

Chart for BLRX.OQ

About

BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to improve cognitive function in... (more)

Overall

No Ratios Available.

Financials

  BLRX.OQ Industry Sector
P/E (TTM): -- 144.58 33.70
EPS (TTM): -- -- --
ROI: -- -2.25 17.35
ROE: -- -6.85 18.21
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$25.00
Provider: Edison Investment Research
$10.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks